Prognostic value of treadmill exercise and dobutamine stress positron emission tomography

Canadian Journal of Cardiology

Volumn 25, Issue 7, 2009, Pages

  Chow, Benjamin J W ^a,b   Al Shammeri, Owayed M ^b   Beanlands, Rob S ^a,b   Chen, Li ^a,b   deKemp, Robert A ^a,b   DaSilva, Jean ^a,b   Ruddy, Terrence D ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Coronary artery disease; Dobutamine; Positron emission tomography; Prognosis; Treadmill exercise

Indexed keywords

ACETYLSALICYLIC ACID; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART RATE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE; CANADA; EXERCISE TEST; METHODOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; SCINTISCANNING; SURVIVAL;

CARDIOTONIC AGENTS; CORONARY ARTERY DISEASE; DOBUTAMINE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 67849121367     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70505-7     Document Type: Article

References (35)

1. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;31:1899-905.
2. Stewart RE, Schwaiger M, Popma J, et al. Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol 1991;67:1303-10.
3. Tamaki N, Yonekura Y, Senda. M, et al. Value and limitation of stress thallium-201 single photon emission computed tomography: Comparison with nitrogen-13 ammonia positron tomography. J Nucl Med 1988;29:1181-8.
4. Tamaki N, Ruddy TD, deKemp R, Beanlands RSB. Myocardial perfusion. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins, 2002:320-33.
5. Yoshinaga K, Chow BJW, de Kemp RA, et al. What is the prognostic value with rubidium-82 perfusion positron emission tomography imaging? J Am Coll Cardiol 2006;48:1029-39.
6. Chow BJW, Ananthasubramaniam K, deKemp RA, Dalipaj MM, Beanlands RSB, Ruddy TD. Comparison of treadmill exercise versus dipyridamole stress as an adjunct to myocardial perfusion imaging with 82Rb positron emission tomography. J Am Coll Cardiol 2005;45:1228-34.
7. Marwick TH, Shan K, Patel S, Go RT, Lauer MS. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am J Cardiol 1997;80:865-70.
8. Marwick TH, Shan K, Go RT, MacIntyre WJ, Lauer MS. Use of positron emission tomography for prediction of perioperative and late cardiac events before vascular surgery. Am Heart J 1995;130:1196-202.
9. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.
10. Chow BJW, Wong JW, Yoshinaga K, et al. Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging. J Nucl Med 2005;46:1095-101.
11. Chow BJW, Beanlands RS, Lee A, et al. Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. J Am Coll Gardiol 2006;47:411-6.
12. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 2001;37:153-6.
13. McNeill AJ, Fioretti P, Mel-Said SM, Salustri A, Forster T, Roelandt JR. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70:41-6.
14. Gibbons RJ, Balady GJ, Timothy Bricker J, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883-92.
15. Schelbert H, Beanlands R, Bengel F, et al. PET myocardial perfusion and glucose metabolism imaging - Part 2: Guidelines for interpretation and reporting. J Nucl Cardiol 2003;10:557-71.
16. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
17. Lauer MS, Lytle B, Pashkow F, Snader CE, Marwick TH. Prediction of death and myocardial infarction by screening with exercise-thallium testing after corcmary-artery-bypass grafting. Lancet 1998;351:615-22.
18. Berman DS, Kang X, Van Train KF, et al. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1998;32:1987-95.
19. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
20. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465-78.
21. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
22. Brown K. Prognosis in stable coronary artery disease. In: Zaret BL, Beller GA, eds. Nuclear Cardiology State of the Art and Future Directions. St Louis: Mosby, 1999:331-45.
23. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993;21:1583-90.
24. Pennell DJ, Underwood SR, Swanton RH, Walker JM, Ell PJ. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991;18:1471-9.
25. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain: Echocardiography, perfusion scintigraphy, or both? Circulation 1997;96:137-47.
26. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997;30:595-606.
27. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97:1474-80.
28. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-67.
29. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano, E. Stress echo results predict mortality: A large-scale multicenter prospective international study. J Am Coll Cardiol 2003;41:589-95.
30. Pingitore A, Picano E, Varga A, et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and doburamine test. J Am Coll Cardiol 1999;34:1769-77.
31. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001;37:754-60.
32. Beanlands R. Positron emission tomography in cardiovascular disease. Can J Cardiol 1996;12:875-83.
33. Gould KL. PET perfusion imaging and nuclear cardiology. J Nucl Med 1991;32:579-606.
34. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/ stress EOG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestaimbi SPECT. J Nucl Cardiol 2006;13:24-33.
35. Nadig MR, Patel CD, Malhotra A. Comparison between dobutamine stress and combination of handgrip exercise with dobutamine stress in myocardial perfusion SPECT. Nucl Med Commun 2007;28:301-4.